AMENDOLARA, ROCCO
AMENDOLARA, ROCCO
DIPARTIMENTO DI MEDICINA SPERIMENTALE
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes
2023 Maddaloni, Ernesto; Coraggio, Lucia; Amendolara, Rocco; Baroni, Marco G; Cavallo, Maria G; Copetti, Massimiliano; Cossu, Efisio; D'Angelo, Paola; D'Onofrio, Luca; Cosmo, Salvatore De; Leonetti, Frida; Morano, Susanna; Morviducci, Lelio; Napoli, Nicola; Prudente, Sabrina; Pugliese, Giuseppe; Park, Kyoungmin; Holman, Rury R; Trischitta, Vincenzo; Buzzetti, Raffaella
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes
2024 Maddaloni, Ernesto; Amendolara, Rocco; Balena, Angela; Latino, Alessandro; Sessa, Rosario Luigi; Buzzetti, Raffaella
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis
2021 Maddaloni, E.; D'Onofrio, L.; Siena, A.; Luordi, C.; Mignogna, C.; Amendolara, R.; Cavallari, I.; Grigioni, F.; Buzzetti, R.
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
2023 D’Onofrio, Luca; Amendolara, Rocco; Mignogna, Carmen; Leto, Gaetano; Tartaglione, Lida; Mazzaferro, Sandro; Maddaloni, Ernesto; Buzzetti, Raffaella
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study
2024 Bodini, Sara; Pieralice, Silvia; D'Onofrio, Luca; Mignogna, Carmen; Coraggio, Lucia; Amendolara, Rocco; Risi, Renata; Salducci, Mauro; Buzzetti, Raffaella; Maddaloni, Ernesto
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study. The CoVaDiab study I
2023 D'Onofrio, Luca; Fogolari, Marta; Amendolara, Rocco; Siena, Antonio; DE FATA, Riccardo; Davini, Flavio; Coraggio, Lucia; Mignogna, Carmen; Moretti, Chiara; Maddaloni, Ernesto; Angeletti, Silvia; Buzzetti, Raffaella
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: a 12‐month, randomized, comparator‐controlled pilot study
2024 Maddaloni, Ernesto; Naciu, Anda M.; Mignogna, Carmen; Galiero, Raffaele; Amendolara, Rocco; Fogolari, Marta; Satta, Chiara; Serafini, Chiara; Angeletti, Silvia; Cavallo, Maria Gisella; Cossu, Efisio; Sasso, Ferdinando Carlo; Buzzetti, Raffaella; Pozzilli, Paolo; Barchetta, Ilaria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes | 2023 | Maddaloni, Ernesto; Coraggio, Lucia; Amendolara, Rocco; Baroni, Marco G; Cavallo, Maria G; Copetti, Massimiliano; Cossu, Efisio; D'Angelo, Paola; D'Onofrio, Luca; Cosmo, Salvatore De; Leonetti, Frida; Morano, Susanna; Morviducci, Lelio; Napoli, Nicola; Prudente, Sabrina; Pugliese, Giuseppe; Park, Kyoungmin; Holman, Rury R; Trischitta, Vincenzo; Buzzetti, Raffaella | |
| Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes | 2024 | Maddaloni, Ernesto; Amendolara, Rocco; Balena, Angela; Latino, Alessandro; Sessa, Rosario Luigi; Buzzetti, Raffaella | |
| Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis | 2021 | Maddaloni, E.; D'Onofrio, L.; Siena, A.; Luordi, C.; Mignogna, C.; Amendolara, R.; Cavallari, I.; Grigioni, F.; Buzzetti, R. | |
| Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications | 2023 | D’Onofrio, Luca; Amendolara, Rocco; Mignogna, Carmen; Leto, Gaetano; Tartaglione, Lida; Mazzaferro, Sandro; Maddaloni, Ernesto; Buzzetti, Raffaella | |
| No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study | 2024 | Bodini, Sara; Pieralice, Silvia; D'Onofrio, Luca; Mignogna, Carmen; Coraggio, Lucia; Amendolara, Rocco; Risi, Renata; Salducci, Mauro; Buzzetti, Raffaella; Maddaloni, Ernesto | |
| Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study. The CoVaDiab study I | 2023 | D'Onofrio, Luca; Fogolari, Marta; Amendolara, Rocco; Siena, Antonio; DE FATA, Riccardo; Davini, Flavio; Coraggio, Lucia; Mignogna, Carmen; Moretti, Chiara; Maddaloni, Ernesto; Angeletti, Silvia; Buzzetti, Raffaella | |
| Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: a 12‐month, randomized, comparator‐controlled pilot study | 2024 | Maddaloni, Ernesto; Naciu, Anda M.; Mignogna, Carmen; Galiero, Raffaele; Amendolara, Rocco; Fogolari, Marta; Satta, Chiara; Serafini, Chiara; Angeletti, Silvia; Cavallo, Maria Gisella; Cossu, Efisio; Sasso, Ferdinando Carlo; Buzzetti, Raffaella; Pozzilli, Paolo; Barchetta, Ilaria |